Caraco Pharmaceutical Laboratories
Caraco Pharmaceutical Laboratories reports record sales for 4Q and full year 2006
Published in Pharma Investments, Ventures and Law Weekly, July 9th, 2006
Sales for Q4 of Fiscal 2006 ending March 31, 2006 were $24.7 million as compared to $17.3 million for the corresponding period of 2005, representing sales growth of almost 43%.
Daniel H. Movens, Caraco's chief executive officer, said "The record increase in sales was primarily due to our team's continued execution of our plan, improved production and sales of our generic equivalent of Ultracet that was launched in the latter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals
Access Pharmaceuticals implements one for five reverse stock split - Aceto Corporation
Aceto to make investment in India by establishing new subsidiary - Aeolus Pharmaceuticals
Aeolus Pharmaceuticals completes $5M financing from new institutional investors - American Diabetes Association
Takeda commits $1.425 million to diabetes association's postdoctoral fellowship programs - BioMS Medical Corp.
BioMS Medical completes $15 million private placement - Cerimon Pharmaceuticals
Cerimon Pharmaceuticals names James Welch as chief financial officer - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
